Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$21.48 USD
-2.18 (-9.21%)
Updated Jul 2, 2024 04:00 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Earnings News For ARCT
-
Arcturus Therapeutics: Q1 Earnings Snapshot
-
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
-
Arcturus Therapeutics: Q4 Earnings Snapshot
-
Arcturus Therapeutics: Q4 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
-
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
-
Arcturus Therapeutics: Q3 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates
-
Arcturus Therapeutics: Q2 Earnings Snapshot
-
Arcturus Therapeutics: Q1 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Q1 Earnings and Revenues Miss Estimates
-
Arcturus Therapeutics (ARCT) Beats Q4 Earnings and Revenue Estimates
-
Arcturus Therapeutics: Q4 Earnings Snapshot
-
Arcturus Therapeutics: Q3 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Tops Revenue Estimates
-
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
-
Arcturus Therapeutics: Q2 Earnings Snapshot
-
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates
-
Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
-
Analysts Estimate Arcturus Therapeutics (ARCT) to Report a Decline in Earnings: What to Look Out for
-
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates
-
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline
-
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates
-
Earnings Preview: Arcturus Therapeutics (ARCT) Q2 Earnings Expected to Decline
-
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates